Analysis of Emerging Therapeutic Approaches for Treating DMD

Abstract

Muscular dystrophy, also known as Duchenne muscular dystrophy (DMD), is a fatal muscle disorder, changes to the DMD gene be the cause of this disease, DMD primarily impacts boys during childhood. For DMD there was no treatment available up until, in recent years, a range of curative approaches to Muscular Dystrophy have been under research; a few among them are development of corticosteroids, viral vector mediated gene therapy, exon skipping, etc. exon-skipping is the one of the optimistic approaches for correcting DMD, this therapy’s main aim is to transform an out-of-frame mutation to convert an out-of-frame mutation into an in-frame mutation, to change of a severe DMD phenotype into a mild phenotype by restoration of reduced dystrophin aspect. 

Country : India

1 Venugopal C. S.2 Dr. Asha K. R.3 Dr. Prakash B. R.

  1. Assistant Professor, Department of Computer Science, Seshadripuram Evening College, Bengaluru, India-560020
  2. Associate Professor, Department of CSE, SSIT, Tumakuru, Karnataka, India-572105
  3. Assistant Professor, Department of Computer Science, Government First Grade College, Tiptur, Karnataka, India-572105

IRJIET, Volume 8, Issue 8, August 2024 pp. 264-267

doi.org/10.47001/IRJIET/2024.808030

References

  1. Hideo SUGITA*1, Shin’ichi TAKEDA*1,“Progress in muscular dystrophy research with special emphasis on gene therapy". PubMed Central, Proc Jpn Acad Ser B Phys Biol Sci, Volume 86(7); Jul21, 2010.
  2. Jianbo Wang and et al, “Computational Methods and Correlation of Exon-skipping Events with Splicing, Transcription, and Epigenetic Factors”, PMC5203767.
  3. Guy L. Odom, Paul Gregorevic, Jeffry S. Chamberlain, “Viral-mediated gene therapy for the muscular dystrophies: Successes, limitations and recent advances”," Biochim Biophys Acta"[jour], Author manuscript; available in PMC Jun 21, 2007.
  4. Jean K Mah, “Current and emerging treatment strategies for Duchenne muscular dystrophy”, doi: 10.2147/NDT.S93873, Published online, Jul 22, 2016.
  5. Masafumi Matsuo, “Antisense Oligonucleotide-Mediated Exon-skipping Therapies: Precision Medicine Spreading from Duchenne Muscular Dystrophy - PMC (nih.gov), JMA J, 2021 Jul 15;4(3):232-240. doi: 10.31662/jmaj.2021-0019. Epic, Jul, 9, 2021.
  6. Naoko Shiba, et.al, “Efficacy of exon-skipping therapy for DMD cardiomyopathy with mutations in act in binding domain1”, VOLUME 34, 102060, DECEMBER 12, 2023.
  7. Akinori Nakamura1, Shin’ichi Takeda, “Exon-skipping therapy for Duchenne muscular dystrophy”, J Neuromuscul Dis"[jour], (Suppl 2): S343–S358, 8, 2021.
  8. Tuffery-Giraud S, et.al, “Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase”, Hum. Mutat., 30: 934-945, Cross ref-PubMed, Scopus (274), 2009.
  9. “Exon Skipping - The exon skipping approach is one method for gene repair, as it targets the pre-mRNA transcript introducing alternative splice sites resulting in ‘skipping’ of one or more targeted exons”, Neuromuscular Disorders (Second Edition), 2022.
  10. Weichen Wang 1, Zhiyi Qin, Zhixing Feng, Xi Wang, Xuegong Zhang., “Identifying differentially spliced genes from two groups of RNA-seq samples”.